0001474064-12-000017.txt : 20120201 0001474064-12-000017.hdr.sgml : 20120201 20120201161117 ACCESSION NUMBER: 0001474064-12-000017 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120120 FILED AS OF DATE: 20120201 DATE AS OF CHANGE: 20120201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nader Francois CENTRAL INDEX KEY: 0001365343 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23272 FILM NUMBER: 12562745 MAIL ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000890465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 870439579 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 BUSINESS PHONE: (908) 450-5300 MAIL ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 4 1 edgar.xml PRIMARY DOCUMENT X0304 4 2012-01-20 0000890465 NPS PHARMACEUTICALS INC NPSP 0001365343 Nader Francois 550 HILLS DRIVE BEDMINSTER NJ 07921 1 1 0 0 President, CEO and Director Options (right to buy) 5.71 2012-01-20 4 A 0 46313 0 A 2019-01-20 Common Stock 46313 46313 D Represents options to purchase the Issuer's Common Stock, $0.001 par value. ("Common Stock"). On January 20, 2009, the Reporting Person was granted an option to purchase 231,563 shares of Common Stock under the Issuer's 1998 Stock Option Plan. The option was to vest and become exercisable in two equal installments on the second and third anniversary of the date of grant, with the actual number of options vesting on such dates determined based on the performance of the Common Stock relative to the performance of company stocks comprising a selected market index. The grant of the option was previously reported on the Reporting Person's Form 4 filed on January 22, 2009. On January 20, 2012, 46,313 options vested based upon the performance of the Common Stock relative to the companies in the selected market index. /s/ Francois Nader, by Edward Stratemeier as attorney-in-fact 2012-02-01